The aim of this study is to discontinue antipsychotics and antidepressants, and to study its effect on Behavioural- and Psychological Symptoms in Dementia (BPSD).
Patients with dementia have cognitive deficits, but also hallucinations, delusions, agitation, aggression and apathy. These symptoms are called Behavioural- and Psychological Symptoms in Dementia (BPSD), and are difficult to treat. Antipsychotic and antidepressant medication is in use, despite its lack of clinical evidence. We will discontinue antipsychotics in one group of 12 patients and antidepressants in one group of 12 patients. Patients should have dementia of Alzheimer- or vascular origin. They should live in Nursing Homes and have no other psychiatric disease for which they receive psychotropic drug. They will be registered with 7 different questionnaires at baseline and after 3, 6, 12 and 24 weeks. The study period is 24 weeks. The questionnaires are filled in by the patients and the nurses at the nursing homes. This is an open labelled study with no control group. Based on the results of this study, we will design a RCT study with placebo-controlled group.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
24
Sykehuset Innlandet HF - Sanderud
Ottestad, Oppland, Norway
Changes in Neuropsychiatric Inventory
Time frame: 24 weeks
Changes in weight
Time frame: 24 weeks
Changes in Cornell's Depression Scale
Time frame: 24 weeks
Changes in UPDRS subscale
Time frame: 24 weeks
Changes in "Quality of Live - Alzheimer Disease"
Time frame: 24 weeks
Changes in Severe Impairment Battery
Time frame: 24 weeks
Changes in Lawton's PADL
Time frame: 24 weeks
Oxazepam given p.n.
Time frame: 24 weeks
Drop outs
Time frame: 24 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.